FFCP PHASE1:Hg19::chr11:30105969..30105977,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=-79bp_to_ENST00000527819_5end | |||
|cluster_id=chr11:30105969..30105977,- | |||
|coexpression_cluster_id=C38 | |||
|description=CAGE_peak_1_at_ENST00000527819_5end | |||
|id=chr11:30105969..30105977,- | |||
|ontology_enrichment_celltype=CL:1001319!4.10e-23!1;CL:1000600!4.10e-23!1;CL:0002097!2.07e-12!2;CL:0000174!1.04e-08!3;CL:0002582!1.12e-08!3 | |||
|ontology_enrichment_celltype_v019=CL:0000138;4.27e-34;6!CL:0000153;2.62e-23;9!CL:0000447;2.62e-23;9!CL:0000327;1.22e-14;15!CL:0000499;1.52e-08;28 | |||
|ontology_enrichment_celltype_v019_2=CL:0000058,4.27e-34,6;CL:0000138,4.27e-34,6;CL:0000153,2.62e-23,9;CL:0000447,2.62e-23,9;CL:0000327,1.22e-14,15;CL:0000499,1.52e-08,28;CL:0000151,5.81e-07,36 | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:3371!1.07e-23!1;DOID:4549!1.07e-23!1;DOID:5861!1.07e-23!1;DOID:6496!1.07e-23!1;DOID:2355!3.28e-23!1;DOID:74!2.59e-12!2;DOID:1287!8.61e-07!4 | |||
|ontology_enrichment_disease_v019=DOID:3371;5.42e-195;1!DOID:4549;5.42e-195;1!DOID:5861;5.42e-195;1!DOID:6496;5.42e-195;1!DOID:201;4.27e-34;6!DOID:0060100;4.27e-34;6!DOID:1115;2.29e-11;20 | |||
|ontology_enrichment_disease_v019_2=DOID:3371,5.42e-195,1;DOID:4549,5.42e-195,1;DOID:5861,5.42e-195,1;DOID:6496,5.42e-195,1;DOID:201,4.27e-34,6;DOID:0060100,4.27e-34,6;DOID:1115,2.29e-11,20 | |||
|ontology_enrichment_uberon=UBERON:0004645!4.10e-23!1;UBERON:0001256!4.10e-23!1;UBERON:0001259!4.10e-23!1;UBERON:0001255!2.90e-12!2;UBERON:0001556!2.90e-12!2;UBERON:0002418!8.31e-09!3;UBERON:0004755!8.31e-09!3;UBERON:0001896!8.96e-09!3;UBERON:0005290!8.96e-09!3;UBERON:0010096!8.96e-09!3;UBERON:0002369!1.04e-08!3;UBERON:0001235!1.04e-08!3;UBERON:0006858!1.04e-08!3;UBERON:0000162!3.44e-07!14;UBERON:0001353!3.44e-07!14;UBERON:0000163!3.44e-07!14;UBERON:0006866!3.44e-07!14;UBERON:0000164!3.44e-07!14;UBERON:0000931!3.44e-07!14;UBERON:0004122!9.09e-07!15 | |||
|ontology_enrichment_uberon_v019=UBERON:0002418;2.39e-66;3!UBERON:0004755;2.39e-66;3!UBERON:0001474;1.85e-12;18!UBERON:0004765;4.34e-09;26!UBERON:0001434;2.32e-07;36 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002418,2.39e-66,3;UBERON:0004755,2.39e-66,3 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.301439377059586,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.116210378459959,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14.9152854108635,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.573409195690071,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.214441591374926,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.078493092850514,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0814032686109745,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@ENST00000527819 | |||
}} |
Latest revision as of 21:24, 23 July 2015
Short description: | p1@ENST00000527819 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_ENST00000527819_5end |
Coexpression cluster: | C38_extraskeletal_rhabdomyosarcoma_adrenal_rectal_mesothelioma_lung_Wilms |
Association with transcript: | -79bp_to_ENST00000527819_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
chondroblast | 4.27e-34 | 6 |
chondrocyte | 4.27e-34 | 6 |
GAG secreting cell | 2.62e-23 | 9 |
carbohydrate secreting cell | 2.62e-23 | 9 |
extracellular matrix secreting cell | 1.22e-14 | 15 |
stromal cell | 1.52e-08 | 28 |
secretory cell | 5.81e-07 | 36 |
Ontology term | p-value | n |
---|---|---|
cartilage tissue | 2.39e-66 | 3 |
skeletal tissue | 2.39e-66 | 3 |
Ontology term | p-value | n |
---|---|---|
chondrosarcoma | 5.42e-195 | 1 |
extraosseous chondrosarcoma | 5.42e-195 | 1 |
myxoid chondrosarcoma | 5.42e-195 | 1 |
extraskeletal myxoid chondrosarcoma | 5.42e-195 | 1 |
connective tissue cancer | 4.27e-34 | 6 |
musculoskeletal system cancer | 4.27e-34 | 6 |
sarcoma | 2.29e-11 | 20 |